معرفی
Christopher Godina is a Postdoctoral Fellow at Lund University Cancer Center (LUCC) within the Faculty of Medicine at Lund University. His research focuses on cancer epidemiology and radiation, with a specific emphasis on breast cancer biology and molecular mechanisms.
- Position: Postdoctoral Fellow, Cancer Epidemiology & Radiation
- Institution: Lund University Cancer Center (LUCC)
- University: Lund University, Faculty of Medicine
- Email: christopher.godina@med.lu.se
- ORCID: 0000-0003-1501-0458
Dr. Godina's expertise spans multiple research areas including Breast Cancer (100%), Caveolin-1 (50%), Patient outcomes (42%), Prospective Cohort Studies (33%), Insulin-Like Growth Factor-Binding Proteins (33%), Therapeutic Procedures (30%), Messenger RNA expression (23%), and Contralateral cancer development (21%). His work contributes to UN Sustainable Development Goal 3: Good Health and Well-being.
Analysis of Dr. Godina's publication record reveals a strong focus on molecular biomarkers in breast cancer, particularly examining Caveolin-1 expression patterns, insulin-like growth factor binding proteins (especially IGFBP7), and their clinical implications. His research spans from basic molecular mechanisms to clinical applications, with studies investigating how these biomarkers can improve risk prediction, prognosis, and treatment selection for breast cancer patients. Notably, his work published in Cell on PCSK9 germline variants driving breast cancer metastasis via LRP1 receptor demonstrates significant impact in the field.
- Highly cited work in Cell (2024) with 11 citation indexes and 28 Mendeley readers
- Multiple publications in high-impact journals including Carcinogenesis, Scientific Reports, and NPJ Precision Oncology
- Research focuses on translating molecular findings to clinical applications
Dr. Godina actively participates in the Lund University Cancer Centre research community, having presented his work at LUCC meetings. His collaborative research involves multiple investigators at Lund University and potentially international partners, as evidenced by his multi-authored publications across various high-impact journals.
